Looking to diversify beyond VITNX? The mutual funds below have historically moved differently from VITNX, which may reduce portfolio volatility when combined in a suitable allocation. The stock ideas table highlights individual companies with the same low-correlation characteristics. Correlation can change and does not guarantee that one asset will rise when another falls.
Best Diversifiers for VITNX
0 mutual funds have low correlation with VITNX (below 0.3), 0 of which are negatively correlated. The least correlated is Fidelity Select Pharmaceuticals Portfolio (FPHAX) (Health & Biotech Equities) with a 1Y correlation of 0.34, down from 0.52 over 5 years.
How candidates are selected| Symbol | Name | Correlation 1Y | Correlation 3Y | Correlation 5Y | Risk / Return Rank | Category | Compare |
|---|---|---|---|---|---|---|---|
| Fidelity Select Pharmaceuticals Portfolio | 0.34 | 0.46 | 0.52 | 90 | Health & Biotech Equities | VITNX vs FPHAX | |
| Goldman Sachs Strategic Volatility Premium Fund | 0.35 | 0.16 | 0.14 | 97 | Large Cap Blend Equities | VITNX vs SVPFX | |
| Federated Hermes MDT All Cap Core Fund | 0.45 | 0.62 | 0.80 | 53 | Large Cap Blend Equities | VITNX vs QIACX | |
| Federated Hermes MDT All Cap Core Fund Class R6 | 0.46 | 0.63 | 0.80 | 50 | Large Cap Blend Equities | VITNX vs QKACX | |
| North Square Preferred and Income Securities Fund | 0.54 | 0.37 | 0.42 | 59 | Preferred Stock | VITNX vs ORDNX |
To view more results, upgrade your current subscription plan.
Build a portfolio that complements VITNX
Add VITNX to the Diversification Analyzer to see how it overlaps with your other holdings and which assets balance it best.
Analyze a portfolio with VITNX